Regulation And Legal
Dr. Reddy's Receives US FDA Rituximab Biosimilar Approval
Dr. Reddy's Laboratories received U.S. FDA approval for its rituximab biosimilar, strengthening its global biosimilars portfolio.
Fresenius Kabi holds exclusive U.S. commercialization rights for the p
